Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,220
archived clinical trials in
HIV / AIDS

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
University of Colorado - The Children's Hospital of Denver
mi
from
Aurora, CO
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
University of Colorado - The Children's Hospital of Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Stroger Hospital of Cook County
mi
from
Chicago, IL
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Stroger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Tulane Medical Center
mi
from
New Orleans, LA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Tulane Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
The Fenway Institute
mi
from
Boston, MA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
The Fenway Institute
mi
from
Boston, MA
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
University of Colorado - The Children's Hospital of Denver
mi
from
Aurora, CO
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
University of Colorado - The Children's Hospital of Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
University of Miami
mi
from
Miami, FL
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
University of South Florida
mi
from
Tampa, FL
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Stroger Hospital and the CORE Center
mi
from
Chicago, IL
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Stroger Hospital and the CORE Center
mi
from
Chicago, IL
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Tulane University
mi
from
New Orleans, LA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Tulane University
mi
from
New Orleans, LA
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Johns Hopkins University
mi
from
Baltimore, MD
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
The Fenway Institute
mi
from
Boston, MA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
The Fenway Institute
mi
from
Boston, MA
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Wayne State University
mi
from
Detroit, MI
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated:  1/12/2018
Baylor College of Medicine
mi
from
Houston, TX
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
Project PrEPare - An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among Young Men Who Have Sex With Men (YMSM) in the United States
Status: Enrolling
Updated: 1/12/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects
Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects
Status: Enrolling
Updated:  1/12/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects
Antiretroviral Localization in Gut-Associated Lymphoid Tissue and Lower Female Genital Tract Tissue of HIV+ Subjects
Status: Enrolling
Updated: 1/12/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated:  1/16/2018
University of South Florida
mi
from
Tampa, FL
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated: 1/16/2018
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated:  1/16/2018
Stroger Hospital of Cook County
mi
from
Chicago, IL
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated: 1/16/2018
Stroger Hospital of Cook County
mi
from
Chicago, IL
Click here to add this to my saved trials
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated:  1/16/2018
Tulane Medical Center
mi
from
New Orleans, LA
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated: 1/16/2018
Tulane Medical Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated:  1/16/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated: 1/16/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated:  1/16/2018
Montefiore Medical Center
mi
from
Bronx, NY
Epic Allies HIV ART Adherence Intervention
Epic Allies: A Gaming Mobile Phone Application to Improve Engagement in Care, Antiretroviral Uptake, and Adherence Among Young Men Who Have Sex With Men (YMSM) and Trans Women Who Have Sex With Men
Status: Enrolling
Updated: 1/16/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Children´s Hospital Los Angeles
mi
from
Los Angeles, CA
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Children´s Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
1st Allergy and Clinical Research Center
mi
from
Englewood, CO
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
1st Allergy and Clinical Research Center
mi
from
Englewood, CO
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
University of South Florida; Asthma, Allergy & Immunology CRU
mi
from
Tampa, FL
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
University of South Florida; Asthma, Allergy & Immunology CRU
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Rush-Presbyterian-St. Luke's Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Children´s Hospital Boston
mi
from
Boston, MA
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Children´s Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Allergy, Asthma & Immunology Assoc.
mi
from
Omaha, NE
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Allergy, Asthma & Immunology Assoc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
The Asthma & Allergy Center, P.C.
mi
from
Papillion, NE
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Pediatric Allergy/Immunology Associates
mi
from
Dallas, TX
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Pediatric Allergy/Immunology Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated:  1/16/2018
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Status: Enrolling
Updated: 1/16/2018
Montefiore Medical Center, Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
Biomarkers for Muscle Function and Aging in Chronic HIV Infection
Biomarkers for Muscle Function and Aging in Chronic HIV Infection
Status: Enrolling
Updated:  1/16/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Biomarkers for Muscle Function and Aging in Chronic HIV Infection
Biomarkers for Muscle Function and Aging in Chronic HIV Infection
Status: Enrolling
Updated: 1/16/2018
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated:  1/17/2018
Tower ID Medical Associates, Inc.
mi
from
Los Angeles, CA
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated: 1/17/2018
Tower ID Medical Associates, Inc.
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated:  1/17/2018
Quest Clinical Research
mi
from
San Francisco, CA
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated: 1/17/2018
Quest Clinical Research
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated:  1/17/2018
Care Resource, Inc.
mi
from
Miami, FL
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated: 1/17/2018
Care Resource, Inc.
mi
from
Miami, FL
Click here to add this to my saved trials
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated:  1/17/2018
Orlando Immunology Center
mi
from
Orlando, FL
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated: 1/17/2018
Orlando Immunology Center
mi
from
Orlando, FL
Click here to add this to my saved trials
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated:  1/17/2018
Shannon Schrader, MD
mi
from
Houston, TX
A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)
A Phase I, Open-Label, Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus
Status: Enrolling
Updated: 1/17/2018
Shannon Schrader, MD
mi
from
Houston, TX
Click here to add this to my saved trials
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated:  1/19/2018
San Francisco Dept. of Public Health iPrEx CRS
mi
from
San Francisco, CA
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated: 1/19/2018
San Francisco Dept. of Public Health iPrEx CRS
mi
from
San Francisco, CA
Click here to add this to my saved trials
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated:  1/19/2018
Stroger Hospital of Cook County/Core Center IPREX CRS
mi
from
Chicago, IL
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated: 1/19/2018
Stroger Hospital of Cook County/Core Center IPREX CRS
mi
from
Chicago, IL
Click here to add this to my saved trials
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated:  1/19/2018
Fenway Community Health iPrEx CRS
mi
from
Boston, MA
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated: 1/19/2018
Fenway Community Health iPrEx CRS
mi
from
Boston, MA
Click here to add this to my saved trials
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated:  1/19/2018
IPEC/FIOCRUZ iPrEx CRS
mi
from
Rio de Janeiro,
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Chemoprophylaxis for HIV Prevention in Men
Status: Enrolling
Updated: 1/19/2018
IPEC/FIOCRUZ iPrEx CRS
mi
from
Rio de Janeiro,
Click here to add this to my saved trials
Bioequivalency Study of Zidovudine Under Fed Conditions
A Single Dose, Two Treatment, Two Period, Two Sequence, Crossover Bioequivalency Study of 300 mg Zidovudine Tablets Under Fed Conditions
Status: Enrolling
Updated:  1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Bioequivalency Study of Zidovudine Under Fed Conditions
A Single Dose, Two Treatment, Two Period, Two Sequence, Crossover Bioequivalency Study of 300 mg Zidovudine Tablets Under Fed Conditions
Status: Enrolling
Updated: 1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Bioequivalency Study of Zidovudine Under Fasting Conditions
A Single Dose, Two Treatment, Two Period, Two Sequence, Crossover Bioequivalency Study of 300 mg Zidovudine Tablets Under Fasting Conditions
Status: Enrolling
Updated:  1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Bioequivalency Study of Zidovudine Under Fasting Conditions
A Single Dose, Two Treatment, Two Period, Two Sequence, Crossover Bioequivalency Study of 300 mg Zidovudine Tablets Under Fasting Conditions
Status: Enrolling
Updated: 1/19/2018
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)
Open-Label, Single-Sequence, Two-Cohort Study to Evaluate the Effect of Darunavir/Cobicistat and Cobicistat on BMS-626529 in Healthy Subjects
Status: Enrolling
Updated:  1/22/2018
GSK Investigational Site
mi
from
San Antonio, TX
A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)
Open-Label, Single-Sequence, Two-Cohort Study to Evaluate the Effect of Darunavir/Cobicistat and Cobicistat on BMS-626529 in Healthy Subjects
Status: Enrolling
Updated: 1/22/2018
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  1/23/2018
University of California, Irvine
mi
from
Irvine, CA
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 1/23/2018
University of California, Irvine
mi
from
Irvine, CA
Click here to add this to my saved trials
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  1/23/2018
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 1/23/2018
Allergy Associates of the Palm Beaches, PA
mi
from
North Palm Beach, FL
Click here to add this to my saved trials
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated:  1/23/2018
LSU Health Sciences Center & Children´s Hospital
mi
from
New Orleans, LA
Tolerability and Safety of IGI, 10% With rHuPH20 in PIDD
Tolerability, Safety and Administration Mode Evaluation of Recombinant Human Hyaluronidase (rHuPH20) Facilitated Subcutaneous Treatment With Immune Globulin Infusion (Human), 10% in Subjects With Primary Immunodeficiency Diseases (PIDD)
Status: Enrolling
Updated: 1/23/2018
LSU Health Sciences Center & Children´s Hospital
mi
from
New Orleans, LA
Click here to add this to my saved trials